Optura Launches New Value Creation Division to Help Organizations Manage and Scale their AI Projects
Jon Hilton appointed to fuel next phase of company growth with support from industry leader Katy Feldner
Optura, healthcare’s leading AI orchestration and evaluation platform, today announced its new Value Creation division, which will focus on building products that meet client needs and ensuring they get the maximum value from the ROAITM platform. Jon Hilton has been appointed as Senior Vice President, Head of AI Value Creation to lead the division. Hilton, a West Point graduate and combat Veteran, brings deep leadership experience in business intelligence, AI, and digital transformation. Prior to joining Optura, he served as the AI and Data Analytics Consulting Practice Leader at LBMC, a top 50 accounting firm, a data analytics Senior Manager at EY, and digital transformation leader at ExxonMobil. During his tenure at LBMC, he more than doubled practice revenue.
Katy Feldner joins the team as Vice President, AI Transformation and Value Creation, where she will focus on building the AI Transformation practice within the division. Feldner brings years of experience spanning digital transformation, product strategy, and enterprise execution. Previously at Elevance Health, she turned AI strategy into real outcomes across utilization management and provider digital platforms, and worked closely with executives and the board on communications that shaped major investment decisions. Prior to Elevance Health, she was a consultant at Deloitte Consulting.
SVP, Head of AI Value Creation
VP, AI Transformation & Value Creation
“Jon and Katy bring deep expertise in AI execution and enterprise transformation at a critical moment for our customers,” said Andy Fanning, CEO of Optura. “Their leadership strengthens our ability to help healthcare organizations move beyond experimentation and into real-world operationalization of AI at scale. With the launch of our Value Creation division, we are further moving beyond providing a service into creating deep partnerships with our clients to help them measure impact, drive accountability, and translate AI investments into measurable financial and clinical outcomes.”
These appointments build on Optura’s rapid adoption among healthcare organizations. With $2B of AI initiatives loaded into the platform on Optura’s ROAITM platform, the Value Creation practice will serve as a bridge between Optura’s Customer Growth and Product teams. The new Value Creation division is a dedicated team of advisors who will help leaders and organizations track, drive and scale high-value AI use cases over time.
“AI’s capabilities are accelerating faster than organizations can adopt them,” said Jon Hilton, SVP of AI Value Creation at Optura. “That’s not a technology problem – it’s an operationalization problem. Too many use cases stall because they aren’t tied to the workflows that matter or to outcomes anyone can measure. Value Creation exists to close that gap, helping organizations point AI at high-value use cases and scale what works. That’s how you move from pilots to true ROAI.”
Optura’s ROAITM is rapidly becoming the platform of choice for helping healthcare organizations bring accountability and measurement to AI, and recognize real returns on AI investment.
Optura has generated over $120.02M in value. 700% ROAITM, and 250 use cases for health systems organizations to-date.
“Driving value from AI requires more than great models, it takes structure, governance, and alignment across teams,” said Katy Feldner, VP, AI Transformation and Value Creation at Optura. “In healthcare especially, AI has to fit into complex workflows and carries more operational risk. I am excited to help organizations bring discipline to how AI is deployed, tracked, and improved over time so they can confidently invest in what works.”
About Optura
Optura helps healthcare organizations get the greatest value from AI. Its ROAITM platform systematically maps an organization’s data onto a unified intelligence layer and translates top priorities into operational AI agents, directly from existing workflows and SOPs. ROAITM simulates expected returns, so healthcare leaders can see projected value before deployment and investment, and then puts the AI agents to work, providing visibility into outcomes, performance and efficiencies in real-time. More than $2.1B of AI initiatives are managed in the platform, with $120 million tracking value at 700% ROAI measured on in-flight initiatives, and 250 new use cases identified. Optura is trusted by enterprise health plans and providers, including Independence Blue Cross, Blue Cross Blue Shield of North Carolina, Capital Blue Cross.
